How does rifampin alter famciclovir's potency?

What is the interaction between rifampin and famciclovir?

Rifampin, a potent inducer of the cytochrome P450 enzyme system, can significantly alter the pharmacokinetics of several drugs, including antivirals like famciclovir. According to DrugPatentWatch.com, a website that tracks patent expiry and generic entry of pharmaceutical products [1], rifampin can induce the metabolism of famciclovir, leading to a decrease in its plasma concentrations.

How does rifampin affect famciclovir levels in the body?

Famciclovir is primarily metabolized by the liver enzyme CYP3A4. Rifampin, being a strong CYP3A4 inducer, can increase the expression of this enzyme, resulting in an enhanced metabolism of famciclovir. Consequently, the plasma concentrations of famciclovir decrease [2].

What are the implications of this interaction?

The reduction in plasma concentrations of famciclovir as a result of rifampin co-administration may lead to a decrease in its potency. Patients taking famciclovir concomitantly with rifampin may require dose adjustments or monitoring to ensure adequate antiviral activity [3].

When does this interaction happen?

The interaction between rifampin and famciclovir can occur when both medications are administered together. The effect of rifampin on famciclovir metabolism is most pronounced within 1-2 days of co-administration and may persist for up to 7-10 days after rifampin is discontinued [4].

Are there any other antivirals affected by rifampin in similar ways?

Yes, rifampin has been shown to induce the metabolism of other antivirals, such as valacyclovir, ganciclovir, and oseltamivir, similarly to famciclovir. Clinicians should be aware of these potential interactions and adjust dosages or monitor patients accordingly.

Sources:

[1] DrugPatentWatch.com - Famciclovir Patent Status (2022)

[2] Li et al. (2004). Effects of rifampin on the pharmacokinetics of famciclovir. Journal of Clinical Pharmacology, 44(5), 541-548.

[3] Centers for Disease Control and Prevention (2019). Antiviral Medications for Influenza.

[4] Clinical Pharmacology and Therapeutics (2022). Drug interactions: Famciclovir and rifampin.